Luteolin Inhibits Indoxyl Sulfate‐Induced ICAM ‐1 and MCP ‐1 Expression by Inducing HO ‐1 Expression in EA .hy926 Human Endothelial Cells
Environmental Toxicology · 2024
DOI: 10.1002/tox.24380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Li-Chien Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Armed Forces Taichung General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Luteolin, Intercellular Adhesion Molecule-1, Indican, Chemokine CCL2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Armed Forces Taichung General Hospital, China Medical University and Asia University, Chung Shan Medical University.
Abstract (Originalsprache)
In patients with chronic kidney disease, the uremic toxin indoxyl sulfate (IS) accelerates kidney damage and the progression of cardiovascular disease. IS may contribute to vascular diseases by inducing inflammation in endothelial cells. Luteolin has documented antioxidant and anti‐inflammatory properties. This study aimed to investigate the effect of luteolin on IS‐mediated reactive oxygen species (ROS) production and intercellular adhesion molecule (ICAM‐1) and monocyte chemoattractant protein (MCP‐1) expression in EA.hy926 cells and the possible mechanisms involved. IS significantly induced ROS production (by 6.03‐fold, p < 0.05), ICAM‐1 (by 2.19‐fold, p < 0.05) and MCP‐1 protein expression (by 2.18‐fold, p < 0.05), and HL‐60 cell adhesion (by 31%, p < 0.05), whereas, luteolin significantly decreased IS‐induced ROS production, ICAM‐1 and MCP‐1 protein expression, and HL‐60 cell adhesion. Moreover, luteolin attenuated IS‐induced nuclear accumulation of p65 and c‐jun. Luteolin dose‐dependently increased heme oxygenase‐1 (HO‐1) expression and the maximum fold induction of HO‐1 by luteolin was 3.68‐fold ( p < 0.05), whereas, HO‐1 knockdown abolished the suppression of ICAM‐1 and MCP‐1 expression by luteolin. Luteolin may protect against IS‐induced vessel damage by inducing HO‐1 expression in vascular endothelial cells, which suppresses nuclear factor kappa B (NF‐κB) and activator protein 1 (AP‐1) mediated ICAM‐1 and MCP‐1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Armed Forces Taichung General Hospital, Taichung, Taiwan.
- National Defense Medical Center, Graduate Institute of Medical Sciences, Taipei, Taiwan.
- Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan.
- Central Taiwan University of Science and Technology, Taichung, Taiwan.
- Department of Nutrition, College of Medical and Health Care, Hung-Kuang University, Taichung, Taiwan.
- Department of Nutrition, China Medical University, Taichung, Taiwan.
ORCID-Profile: Haw-Wen Chen, Chien-Chun Li
Förderung
- Armed Forces Taichung General Hospital
- China Medical University and Asia University
- Chung Shan Medical University
Zitieren
APA
Chang, L. C., Yeh, E. L., Chuang, Y. C., Wu, C. H., Kuo, C. W., Lii, C. K., Yang, Y. C., Chen, H. W., & Li, C. C. (2024). Luteolin Inhibits Indoxyl Sulfate‐Induced ICAM ‐1 and MCP ‐1 Expression by Inducing HO ‐1 Expression in EA .hy926 Human Endothelial Cells. Environmental Toxicology. https://doi.org/10.1002/tox.24380
Vancouver
Chang LC, Yeh EL, Chuang YC, Wu CH, Kuo CW, Lii CK, et al. Luteolin Inhibits Indoxyl Sulfate‐Induced ICAM ‐1 and MCP ‐1 Expression by Inducing HO ‐1 Expression in EA .hy926 Human Endothelial Cells. Environmental Toxicology. 2024. doi:10.1002/tox.24380
BibTeX
@article{Chang2024,
author = {Chang, Li-Chien and Yeh, En-Ling and Chuang, Ya-Chi and Wu, Chia-Hsuan and Kuo, Chia-Wen and Lii, Chong-Kuei and Yang, Ya-Chen and Chen, Haw-Wen and Li, Chien-Chun},
title = {Luteolin Inhibits Indoxyl Sulfate‐Induced ICAM ‐1 and MCP ‐1 Expression by Inducing HO ‐1 Expression in EA .hy926 Human Endothelial Cells},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24380}
}
EUVIMED